![]() | ![]() |
Formats:
|
|||||||||||||||||||||||||||||||||||
Copyright © 1998, The National Academy of Sciences Symposium Paper The Atomic Bomb Casualty Commission in retrospect Department of Biology, Indiana University Bloomington, IN 47405 *To whom reprint requests should be addressed. e-mail:
fputnam/at/indiana.edu. This paper was presented at the symposium “A Song Among the
Ruins: 50 Years of the Japanese/Academy Cooperative Studies of Atomic
Bomb Survivors,” organized by John E. Dowling and Alvin G. Lazen and
held at the 134th Annual Meeting of the National Academy of Sciences on
April 30, 1997. This article has been cited by other articles in PMC.Abstract For 50 years, the Atomic Bomb Casualty Commission (ABCC) and its
successor, the Radiation Effects Research Foundation (RERF), have
conducted epidemiological and genetic studies of the survivors of the
atomic bombs and of their children. This research program has provided
the primary basis for radiation health standards. Both ABCC
(1947–1975) and RERF (1975 to date) have been a joint enterprise of
the United States (through the National Academy of Sciences) and of
Japan. ABCC began in devastated, occupied Japan. Its mission had to be
defined and refined. Early research revealed the urgent need for long
term study. In 1946, a Directive of President Truman enjoined the
National Research Council of the National Academy of Sciences to
develop the program. By 1950, ABCC staff exceeded 1,000, and clinical
and genetic studies were underway. Budgetary difficulties and other
problems almost forced closure in 1953. In 1955, the Francis Report led
to a unified epidemiological study. Much progress was made in the next
decade, but changing times required founding of a binational nonprofit
organization (RERF) with equal participation by Japan and the United
States. New programs have been developed and existing ones have been
extended in what is the longest continuing health survey ever
undertaken. The Origins of the Atomic Bomb Casualty Commission (ABCC) The world knows too little about the history and accomplishments
of the ABCC and of its successor, the Radiation Research Effects
Foundation (RERF). Fortunately, as the 50th anniversary of the founding
of ABCC approached, a number of books and papers were published (1–7).
These and others (8–10) describe the early trials and the successful
evolution of a unified research program—a program that has provided
the primary basis for radiation health standards throughout the world. For 50 years—in the longest continuing investigation of its
kind—medical and scientific studies have been done of the survivors of
the atomic bombing of Hiroshima and Nagasaki and of the survivors’
children. Throughout this period, the National Academy of Sciences
(NAS) via its operating arm, the National Research Council (NRC), has
shared responsibility for undertaking these studies with the Japanese
government. Initially, this work was done through the founding and
supervision of ABCC; later, it was done through oversight of the
American role in RERF, the successor to ABCC. Of course, ABCC was
always a partnership enterprise of NAS and the Japan National Institute
of Health (JNIH), and RERF still is supported equally by the Japan
Ministry of Health and Welfare and the United States government. The
focus of this paper will be on the early history of ABCC rather than on
RERF. For brevity, reference frequently will be made to the Academy
(i.e., NAS) or to NRC, rather than to the NRC–NAS complex. ABCC began in a period of chaos in Japan, which was recovering from the
devastation of war and the anguish of defeat and military occupation.
ABCC had no precedent in the history of medicine, nor had the Academy
ever undertaken an investigation of such magnitude before—nor has it
since. Indeed, the Academy had no idea of what it was getting into; if
it did, it probably would have never founded ABCC. One measure of the
magnitude of the enterprise is that the Academy had approximately the
same number of employees at ABCC in Japan in 1950 (1,061, of whom only
143 were not Japanese) as it has today in the entire NRC–NAS complex
(≈1,100). There were conflicting objectives in the undertaking. On the American
side, there was recognition of the urgent need for research on the
medical and genetic aftereffects of radiation, but the military
authorities also had interest in the offensive and defensive
implications of atomic radiation. On the Japanese side, there was an
unmet expectation of medical care coupled with a suspicion of the
American motives. There were other problems: the uncertain commitment
within the Atomic Energy Commission (AEC), which was the funding agency
(and at times uncertainty also within NAS), the resulting financial
problems, and the changing direction of the research. Japan was under
military occupation (the Occupation). Hiroshima and Nagasaki had been
destroyed. The country was in chaos, and the civil structure and
infrastructure had to be restored. All of these elements led to a
troubled first decade for ABCC. Year One after the Bombing Within days after the bombing of Hiroshima on August 6, 1945 and
of Nagasaki on August 9, the Japanese sent in medical and scientific
teams. Under the leadership of Dr. Masao Tsuzuki, head of the Japanese
National Research Council, they collected much critical clinical data
in the first month. Their studies were invaluable but were largely
suppressed from publication by the Occupation. Nominally, this was
because Dr. Tsuzuki had the rank of rear admiral in the Japanese Navy,
but the more likely cause was the military penchant for secrecy. In September 1945, the U.S. Army, the Navy, and the Manhattan District
sent teams to Hiroshima and Nagasaki to study the medical effects of
the atomic bombs. These were headed by Col. Ashley W. Oughterson for
the Army, Capt. Shields Warren for the Navy, and Col. Stafford L.
Warren for the Manhattan District. By order of General Douglas
MacArthur, the Supreme Commander, these units and the Japanese groups
under Dr. Tsuzuki were merged on October 12, 1945 to form the Joint
Commission for the Investigation of the Effects of the Atomic Bombs.
The American personnel consisted of more than 60 specialists. Dr.
Tsuzuki assembled more than 90 Japanese physicians and scientists. A
preliminary report was issued by the Joint Commission; however, the
vast amount of data collected was filed as a series of classified
reports, some of which were published much later (9). Nonetheless, it
was soon clear that a careful long term follow–up study of the
survivors and their children was needed and that the Joint Commission
set up by the military was not the appropriate agency to do this. The Truman Directive, November 26, 1946 Ever since the military occupation, the Truman directive of
November 26, 1946 has been cited as the mandate for NAS oversight of
ABCC and thus of RERF. The origins of the letter from Secretary of the
Navy James Forrestal to Truman, which was signed as a Presidential
Directive, are as follows. On May 28, 1946 after the Joint Commission had returned to the United
States and rendered its report, Norman T. Kirk, the Surgeon General of
the Army, wrote to Lewis H. Weed, the Chairman of the NRC–NAS Division
of Medical Sciences. General Kirk pointed out the desirability of a
careful follow-up study of the Japanese casualties, and he suggested
that NRC appoint a group to plan the study. In response, NRC convened a
conference with both civilians and representatives of the services in
attendance. One recommendation of the conference was for “the
establishment of a permanent organization for continuing long term
study of the biological and medical effects of the atomic bomb.” At General Kirk’s request, the Division of Medical Sciences suggested
a number of possible consultants. Those selected were Dr. Austin M.
Brues, a radiobiologist from the University of Chicago, Dr. Paul S.
Henshaw of the Manhattan District, Lt. Col. Carl F. Tessmer, Medical
Corps, Army of the United States (later the first permanent Director of
ABCC), and Lt. James V. Neel, Medical Corps, Army of the United States
(an M.D.—Ph.D. geneticist). Neel was the first Director, albeit in an
Acting capacity, and ever since he has directed the genetics program of
the children of the survivors. This group met in Japan in November
1946. According to anecdotes, it called itself the “Atomic Bomb
Casualty Commission” for lack of an official title. Soon after, the
Academy received the Presidential Directive (Fig.
(Fig.1);1
In a January 2, 1980 letter to Gilbert W. Beebe [who had attended
that first meeting of the Committee on Atomic Casualties (CAC)],
Shields Warren stated “The November 26, 1946 directive of Truman’s
was one that I had written and had persuaded Ross McIntire [Surgeon
General of the Navy] to take to Truman for his signature.” Whatever
its origin, the Presidential Directive became the charter for the
founding of ABCC by NAS. Because ABCC did not initially have official
status in the Occupation, Lt. Neel sometimes had to show a copy of this
letter to staff of the Occupation or to the Japanese local authorities
to overcome red tape and to obtain cooperation. The first laboratory was established in coaches on a train that the
U.S. military had set up to handle unexpected disasters or possible
epidemics (Fig. (Fig.2).2
Until recently, historical accounts of ABCC and RERF were sparse, and
the archives were unorganized. However, as this Symposium shows, there
is renewed interest that has been evoked by the 50th anniversary of the
A-bombs and the half-century of research on the survivors and their
children by ABCC and RERF. A series of publications has come out in the
past few years, including important books by speakers in this Symposium
(1–3, 7). Much other useful information can be found on the RERF home
page on the Internet (search Yahoo for RERF or go to
http://www.rerf.or.jp/eigo/experhp/rerfhome.htm). There are
also important archival resources at NAS, at the Texas Medical Center
in Houston, and at RERF in Hiroshima. The most valuable resources are
the memories of the pioneers of ABCC and RERF, many of whom contributed
brief anecdotal vignettes in a special issue of the RERF
Newsletter (10) The Troubled First Decade (1947–1957) The first decade of ABCC was a period of uncertainty, marked by
some important accomplishments but marred by financial problems and
lack of a clear scientific direction. The design and the results of the
clinical and scientific studies are described elsewhere in this issue
of Proceedings (11–13). Here, the emphasis will be on the
early history of ABCC and how its relationship to NAS affected the
ongoing program at Hiroshima and Nagasaki. The NRC–NAS Committee on Atomic Casualties in the Division of Medical
Sciences had the initial responsibility for oversight of the ABCC
program. The Committee was founded on March 1, 1947 and held its first
meeting March 25, 1947. (The minutes of this and subsequent meetings
are referred to here by date as CAC Minutes and are on file in the NAS
Archives.) This first meeting was attended by representatives of the
armed services who gave reports on the observations made thus far and
offered suggestions on how the future investigation should be designed
and conducted. Dr. Thomas M. Rivers, the Chairman, called on Drs. Brues
and Henshaw for a report on the activities and observations of ABCC,
which by now had accepted ABCC as the official name. Funding was an
urgent item of business. Indeed, funding has been a problem since the very inception of ABCC.
The Presidential Directive did not provide a source for financing. The
Academy bore some initial expenses and assumed that support would come
from the Army, Navy, and the AEC. However, the Bureau of the Budget
ruled that funds could not be provided by the Army or Navy for external
grants, so the AEC was approached even though it also was just being
established as the successor to the Manhattan Engineering District (the
Manhattan Project) (CAC Minutes, 6 June, 1947). The initial ABCC team functioned as an interim organization until the
AEC was organized. Much of the early expense was borne by the
Occupation. Indeed, the first contract of the AEC with NAS was not
signed until April 13, 1948, but it was made retroactive to July 1,
1947 for a 2-year period. The contract was renewed with modifications
through March 31, 1975 when ABCC was dissolved and RERF was founded.
Thus, the research program of ABCC was funded for a continuous period
of almost 28 years by contracts of the AEC with NAS. The original
contract—or at least an abbreviated version reproduced by Allen
(14)—does not even mention ABCC. Referring to NAS as “the
Contractor,” it states:
Under this contract, the Academy had the primary responsibility,
the operational authority, and the financial support to conduct the
necessary studies, but the outlines of the program still had to be
developed. This charge was given to CAC acting for NRC–NAS. One of the
most important actions of CAC occurred at its second meeting on May 1,
1947 when it received Neel’s report on genetic studies (CAC Minutes,
May 1, 1947). At its third meeting on June 6, 1947, CAC adopted plans
for a conference on genetics (CAC Minutes, June 6, 1947). This
conference was held and later was published as a CAC report, actually a
report of the Subcommittee on Genetics, which was largely prepared by
Neel (15). There was much uncertainty at the time whether significant
results could be guaranteed from such a large, expensive, and
unprecedented study (2). Yet, this report laid the basis for the
genetics program, one of the two major research areas of both ABCC and
RERF, and an evolving program that continues to this day (12). ABCC rapidly expanded in the period 1948–1950. In early 1948, ABCC
began with a staff of 3 American and 25 Japanese nationals (Fig.
(Fig.4),4
As increasingly negative findings accumulated and the Korean War
(1950–1953) began, questions about the value of ABCC research were
raised and financial constraints ensued. Even Detlev W. Bronk, then
President of NAS and an early supporter of ABCC, now voiced concern. In
1950 and again in 1951, the AEC sent a number of consultants to Japan
to review ABCC, and they issued critical reports. Thereupon, AEC denied
budgetary increases requested by NAS. Other consultants such as John Z.
Bowers and Joseph Wearn, both medical deans, questioned the
justification for ABCC. As a result, AEC decided to reduce the
NAS-proposed budget for fiscal year 1952 from 3.5 million dollars to 1
million. Dr. Thomas M. Rivers, Chairman of CAC, interpreted this action
as an obvious order by AEC to discontinue ABCC. Bronk, as President of
NAS, was ambiguous about the future of ABCC. In exasperation, CAC, on
February 3, 1951, voted to terminate ABCC (CAC Minutes). The motion
ordered “that the ABCC be discontinued because of lack of financial
support.” In time, the furor subsided as AEC and NAS worked out their problems;
CAC was reorganized to include AEC representatives, and it became an
advisory group, losing its operational responsibility. However,
lingering doubts remained that prompted a thorough review of the entire
program by an NRC–NAS committee, later known as the Francis Committee. The Francis Committee Many problems confronted ABCC during the early years and thwarted
its development and the systematic planning of research. These include
the devastation of Japan, the constraints of the military occupation,
cultural clash, difficulty in attaining subject cooperation, and
activist opposition that incited distrust of ABCC motives. Abetted by
budgetary uncertainty, these problems led to sagging staff morale and
difficulty in recruiting and retaining American staff. Added to this
was the uncertain legal status of ABCC as the Occupation began to
unwind. Fortunately, the ambiguous status of ABCC was resolved by
establishing it as an agency attached to the U.S. Embassy through an
exchange of notes verbales with the Japanese government on
October 22–23, 1952 (reproduced in Allen, ref. 14). However, most of
the other problems had to be solved at the local level. Throughout this period, and despite the geographical distance, the
Academy aided ABCC in many ways. The prestige and political
independence of NAS was a major factor in gaining confidence of the
Japanese. As described later, the most important actions of the Academy
were the appointment of the Francis Committee in 1955 and of Dr. George
B. Darling as Director in 1957. The conjunction of these actions led to
a decisive turning point in the program. During this uncertain period, ABCC was kept alive and then
reinvigorated by Dr. R. Keith Cannan, a biochemist, who became chairman
of the NRC Division of Medical Sciences and thus the executive director
of ABCC for NRC–NAS. Cannan proved to be a key leader in the design
and development of the role of ABCC. Veterans of the program affirm
that, without his determined support and resolute guidance, ABCC might
have closed its doors. However, at first he was discouraged by the
deteriorating state of ABCC and by the financial problems. He was on
the verge of recommending termination of ABCC but was restrained by
Bronk. Then came the Woodbury mortality report in 1954 (16). Gilbert
Beebe and Seymour Jablon, who were reviewers of the report, have
asserted to me that it was a deciding factor in the continuance and
restructuring of ABCC. The report noted an increased mortality for
exposed survivors and indicated the need for systematic study of the
mortality situation in the two cities, but little was being done. Cannan recognized the need for a thorough scientific review of the ABCC
program that would produce recommendations for its reorganization and
future strategy. At his direction, an ad hoc NRC–NAS
committee was formed that came to be known as the Francis Committee.
The committee was chaired by Thomas Francis, Jr., an eminent
epidemiologist and virologist, from the University of Michigan. The
other members were Seymour Jablon of the Follow-Up Agency, NRC–NAS,
and Felix E. Moore, from the National Heart Institute. Accompanied by
Cannan, the committee made a 3–week visit to Japan in October, 1955
and conducted an intensive review of the objectives of ABCC and of its
research program (17). Their report, the “Francis Report,” made
sweeping recommendations for reorganization of the program and for
focus on integrated epidemiological and genetic study of a fixed
population defined by a “Master Sample.” The Francis Report recommended a comprehensive epidemiologic approach,
later called the “Unified Study Program,” that included a
continuing morbidity survey, clinical study, postmortem detection, and
death certificate analysis. After review by Japanese and American
experts, a series of programs (later called platform research
protocols) were instituted that continue in modified form to this day.
These were the Life Span Study, Adult Health Study, Pathology Study,
and F1 Mortality Study—all of which are
described in this Symposium (11–13). The Report also proposed closer
association with Hiroshima Medical School and with JNIH, and it urged
development of relationships with corresponding departments of American
medical schools and with the U.S. National Institutes of Health and
similar agencies. The Academy was prompt and effective in developing these interactions.
In 1956, members of the Francis Committee returned to Japan for 7 weeks
to consult on implementation of the Unified Study Program. In August,
four U.S. Public Health Service (USPHS) physicians were assigned to
ABCC—the first of many who later served with ABCC. In 1957, Japanese
physicians were appointed as Associate Directors at Hiroshima and
Nagasaki. One of the most important events was Cannan’s recruitment of
Dr. George B. Darling as Director of ABCC in June 1957. ABCC Redux: George Darling and the Implementation of the Francis
Report (1957–1968) One of the recurrent problems of ABCC had been the lack of
continuity in leadership. In the first decade, there were six
Directors, most of whom served only for a year or two. Darling’s
tenure was for 15 years (1957–1972), and he continued to advise
thereafter. He took many steps to recognize the accomplishments of the
Japanese and to further their involvement in joint studies. During his
tenure, radiation dosimetry research programs were undertaken. In 1965,
this led to the Tentative 1965 Doses, or T65D values, the system that
was used until the DS86 dosimetry system was adopted in 1986. The
physical facilities of ABCC at Hiroshima and Nagasaki were expanded.
With the aid of grants from the governments of the United States and
Japan, hospital units were constructed at Hiroshima University and
Nagasaki University to facilitate the care of A-bomb survivors.
Although not all of these advances could be attributed directly to
Darling, they were greatly facilitated by the environment he created
and the increasing success of the Unified Study Program. While Darling worked to cultivate closer associations with the
Japanese, Cannan in Washington mobilized the resources of the Academy
to develop collaboration with American medical institutions. ABCC
departments became associated with corresponding departments in
outstanding medical schools; for example, the ABCC Department of
Medicine with Yale, Pathology with University of California, Los
Angeles, and Statistics with the Medical Follow-Up Agency of NRC–NAS
through Gilbert W. Beebe. A total of 54 U.S. Public Health Service
physician officers was assigned to various departments of ABCC in the
period 1956 through 1975. All of these actions greatly facilitated
recruitment of personnel and strengthened the professional staff. The Radiation Research Foundation Despite increasing collaboration with Japanese and American
medical institutions and the concurrent progress in the epidemiological
and genetics programs, all was not well at ABCC. Anti-ABCC resentment
was kindled by the resurgent nationalism in Japan and by political
activism of the Hibakusha (the atomic bomb survivors). There was an
uneasy tension because ABCC was only nominally a joint
Japanese—American enterprise. Of course, ABCC always had been a
cooperative study by the Americans and Japanese. Some Japanese held
important administrative and professional positions. In fact, the
majority of the personnel were Japanese. For example, in 1958, the
personnel strength of 876 included 50 foreign and 826 Japanese
nationals; yet, only 30 of the latter were from JNIH, and the rest were
employees of the Academy (14). Furthermore, in the 1960s, Japan was reestablishing its industrial base
and rebuilding its national ethos. Increasingly, there was need for
more formal recognition of the Japanese role through an independent
binational structure. The situation was exacerbated by financial
problems and the need for more secure funding. The economic revival of
Japan, inflation, and the declining value of the dollar relative to the
yen combined to cause a financial crisis. Budgetary pressures resulted
in successive reductions in personnel and limitations on expenditures.
It was time to conduct an official review of the administrative
structure, the program priorities, and the financing of ABCC, but
progress was slow. Undoubtedly, the major driving force was the
financial crisis. Only the intervention of the National Institutes of
Health National Cancer Institute averted a major reduction in staff in
1972–1973. Anecdotal evidence indicates that action in Tokyo finally
was prompted by the AEC threat of a massive layoff of staff, an action
unprecedented in Japan. The negotiations for a private binational structure for a successor to
ABCC and for equal sharing by Japan and the United States in its
financial support were complex, and the principle was unprecedented.
Binational negotiations proceeded in 1974. Major impetus was given by
Dr. Philip Handler, President of NAS, after his visit to ABCC in
October of that year. On November 5–8, 1974, a meeting was held in
Tokyo that included representatives of the following: the Japanese
Ministries of Foreign Affairs and of Health and Welfare, AEC, NAS, the
U.S. Embassy, JNIH, and ABCC (Fig.
(Fig.5).5
Organization of RERF The principal change in the transition of ABCC to RERF was in the
organizational structure rather than in the scientific program. In
anticipation of the changeover, Handler had appointed an ad
hoc NAS committee to make a scientific review of the laboratories,
clinics, and research programs at Hiroshima and Nagasaki. This
committee, headed by the eminent geneticist Dr. James F. Crow, visited
Japan in February 1975. Their report, known as the Crow Report,
recommended continuation and strengthening of the major elements of the
ABCC program and the early implementation of a program in biochemical
genetics (18). This strengthening and implementation were done and led
to many important studies described in this Symposium (11–13). Financial problems have beset ABCC and RERF from their inception to
this very day. The Act of Endowment is a misnomer. For the endowment,
the Americans contributed the existing buildings and equipment, and the
Japanese gave an equivalent amount of money (¥360 million). For
perspective, the latter sum is only approximately one-third of the
amount paid by each nation for the 1975 budget. A basic problem is that
RERF is funded by annual appropriations and the U.S. share is paid in
yen. The exchange rate was ≈360 yen to the dollar in the 1970s and
now is only approximately one-third of that. Despite the recent
recovery of the dollar, the frequent and sometimes precipitous decline
in the exchange rate coupled with inflation in Japan and stringency in
the U.S. national budget has led to repeated crises that are not
described here. RERF, which replaced ABCC on April 1, 1975 is incorporated as a private
nonprofit foundation under Japanese law. At least to this date, RERF
has been funded equally by the Government of Japan through the Ministry
of Health and Welfare and by the Government of the United States. The
American share was provided through NAS under a contract (later a
grant) from the Department of Energy (1977 to date) and by its
predecessor, the Energy Research and Development Administration
(1975–1977). The unique feature of the administrative structure of
RERF is the equal sharing of the positions of directors and scientific
advisors by Japanese and Americans. The current status and organization
of RERF are reported in this issue of Proceedings (11); the
history of the first decade is summarized elsewhere (19). In closing, one must give tribute to the veterans of the early days of
ABCC and RERF. Some are here today, but only a few have been named
above. Without their zeal and unmitigating efforts and without the aid
of the loyal Japanese and American staff, NAS participation in ABCC and
RERF would have withered, and the half century of studies of the atomic
bomb survivors could not have been conducted. Acknowledgments I thank the many persons who have provided historical background,
helpful comments, and copies of letters, manuscripts, and photographs
from personal files. In particular, I thank the following: Gilbert W.
Beebe, Charles W Edington, Howard B. Hamilton, Seymour Jablon, Robert
W. Miller, James V. Neel, and William J. Schull. Reports and archival
material were provided by Seymour Abrahamson and Itsuzo Shigematsu of
RERF, Daniel Barbiero of the NAS Archives, and John D. Zimbrick of the
Board of Radiation Effects Research of NRC–NAS. ABBREVIATIONS
References 1. Schull W J. Song Among the Ruins. Cambridge, MA: Harvard. Univ. Press; 1990. 2. Neel J V. Physician to the Gene Pool. New York: Wiley; 1994. 3. Neel J V, Schull W J. The Children of the Atomic Survivors. A Genetic Study. Washington, DC: National Academy Press; 1991. 4. Putnam F W. Perspect Biol Med. 1994;37:515–545. [PubMed] 5. Lindee M S. Suffering Made Real. American Science and the Survivors at Hiroshima. Chicago: Univ. Chicago Press; 1994. 6. Yamazaki J N. Children of the Atomic Bomb. An American Physician’s Memoir of Nagasaki, Hiroshima, and the Marshall Islands. Durham, NC: Duke Univ. Press; 1995. 7. Schull W J. Effects of Atomic Radiation. A Half-Century of Studies from Hiroshima and Nagasaki. New York: Wiley; 1995. 8. Beebe G W. Epidemiol Rev. 1979;1:184–210. [PubMed] 9. Oughterson A W, Warren S. Medical Effects of the Atomic Bomb in Japan. New York: McGraw–Hill; 1956. 10. RERF Newsletter 14, March 1, 1988. 11. Shigematsu I. Proc Natl Acad Sci USA. 1998;95:5424–5425. [PubMed] 12. Neel J V. Proc Natl Acad Sci USA. 1998;95:5432–5436. [PubMed] 13. Schull W J. Proc Natl Acad Sci USA. 1998;95:5437–5441. [PubMed] 14. Allen L R. A General Report on the ABCC-JNIH Joint Research Program. Hiroshima, Japan: RERF; 1978. 15. Genetics Conference, Committee on Atomic Casualties, National Research Council. Science. 1947;106:331–333. 16. Woodbury L A, Holmes R R, Scott J K. Death Certificate Survey: Hiroshima 1950–1954 (Preliminary Report). Hiroshima, Japan: ABCC; 1954. 17. Francis T, Jr, Jablon S, Moore F E. Report of Ad Hoc Committee for Appraisal of ABCC Program. Hiroshima, Japan: ABCC TR 33–59; 1955. 18. Crow J F, Kaplan H S, Marks P A, Miller R W, Storer J B, Upton A C, Jablon S. Report of the Committee for Scientific Review of ABCC, February 1975. Technical Report 21–75. Hiroshima, Japan: ABCC; 1975. 19. Shigematsu I, Kagan A. Radiation Effects Research Foundation: The First 10 Years 1975–1985. Hiroshima, Japan: RERF; 1985. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
||||||||||||||||||||||||||||||||||
Epidemiol Rev. 1979; 1():184-210.
[Epidemiol Rev. 1979]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5424-5.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5437-41.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5432-6.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5424-5.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5437-41.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5424-5.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5437-41.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5424-5.
[Proc Natl Acad Sci U S A. 1998]